Gamida Cell Ltd. - Ordinary Shares (GMDA): Price and Financial Metrics

Gamida Cell Ltd. - Ordinary Shares (GMDA): $2.29

-0.02 (-0.87%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

Add GMDA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#267 of 381

in industry

GMDA Price/Volume Stats

Current price $2.29 52-week high $3.66
Prev. close $2.31 52-week low $0.56
Day low $2.28 Volume 777,381
Day high $2.36 Avg. volume 3,345,541
50-day MA $1.54 Dividend yield N/A
200-day MA $1.69 Market Cap 170.33M

GMDA Stock Price Chart Interactive Chart >


Gamida Cell Ltd. - Ordinary Shares (GMDA) Company Bio


Gamida Cell Ltd. is a clinical stage biopharmaceutical company, which engages in the development of cell therapies that are designed to cure cancer and rare serious hematologic diseases. Its products pipeline include NiCord and NAM-NK. The company was founded by Tony Peled and Menashe Levy in 1998 and is headquartered in Jerusalem, Israel.


GMDA Latest News Stream


Event/Time News Detail
Loading, please wait...

GMDA Latest Social Stream


Loading social stream, please wait...

View Full GMDA Social Stream

Latest GMDA News From Around the Web

Below are the latest news stories about GAMIDA CELL LTD that investors may wish to consider to help them evaluate GMDA as an investment opportunity.

Gamida Cell to Present Corporate Highlights at the Jefferies Healthcare Conference

BOSTON, May 31, 2023--Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that Michele Korfin, Chief Operating and Chief Commercial Officer, will present corporate highlights at the upcoming Jefferies Healthcare Conference on June 8, 2023 at 9:30 a.m. ET.

Yahoo | May 31, 2023

Data To Be Presented on Gamida Cell Natural Killer (NK) Cell Therapy Candidate GDA-201 at the International Society for Cell & Gene Therapy 2023 Annual Meeting

BOSTON, May 31, 2023--Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that an oral presentation highlighting Gamida Cell’s investigational natural killer (NK) cell therapy candidate GDA-201 will be shared at the International Society for Cell and Gene Therapy (ISCT) 2023 Annual Meeting. The meeting takes place May 31-June 3 in Paris, France.

Yahoo | May 31, 2023

Gamida Cell Appoints Terry Coelho as CFO

BOSTON, May 22, 2023--Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced the appointment of Terry Coelho as Chief Financial Officer effective immediately. Shai Lankry, who has served as the company’s CFO for the past five years, is stepping down as CFO today and will leave the company June 2.

Yahoo | May 22, 2023

Breakeven On The Horizon For Gamida Cell Ltd. (NASDAQ:GMDA)

Gamida Cell Ltd. ( NASDAQ:GMDA ) is possibly approaching a major achievement in its business, so we would like to shine...

Yahoo | May 17, 2023

Gamida Cell Ltd. (GMDA) Q1 2023 Earnings Call Transcript

Gamida Cell Ltd. (GMDA)

Q1 2023 Results Conference Call

May 15, 2023 04:30 PM ET

Company Participants

Mike Kuczkowski - Corporate Communications

Abbey Jenkins - President and CEO

Michele Korfin - COO and Chief Commercial Officer

Ronit Simantov - Chief Medical Officer and Scientific Officer

Shai Lankry - CFO

Conference Call Participants

Edward Tenthoff - Piper Sandler

Gil Blum - Needham & Company

Vernon Bernardino - H.C. Wainwright

Mark Breidenbach - Oppenheimer

Presentation

Operator

Ladies and gentlemen, thank you for standing by. Welcome to the Gamida Cell’s Conference Call for the First Quarter 2023 Financial Results...

SA Transcripts on Seeking Alpha | May 16, 2023

Read More 'GMDA' Stories Here

GMDA Price Returns

1-mo 38.79%
3-mo 37.13%
6-mo 77.52%
1-year 5.05%
3-year -52.88%
5-year N/A
YTD 77.52%
2022 -49.21%
2021 -69.73%
2020 95.12%
2019 -56.74%
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!